Why the study?
Does defibrillation threshold testing improve mortality, efficacy, or safety in patients undergoing de novo ICD implantation?
Population
9740 patients undergoing de novo implantable cardioverter-defibrillator (ICD) implantation across 13 studies
Comparison
Defibrillation threshold testing at the time of… vs No DFT testing
Design
Meta-analysis
Authors
Loading...
Omitting routine DFT testing at ICD implantation appears safe; confirms and extends the SIMPLE trial's findings against mandatory testing.
Does defibrillation threshold testing improve mortality, efficacy, or safety in patients undergoing de novo ICD implantation?
Defibrillation threshold testing at de novo ICD implantation does not significantly improve mortality, shock efficacy, or safety, suggesting it should no longer be compulsory.
Phan et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: